Bayer Raises Outlook as Pharma Recovery Narrows Third-Quarter Loss
Bayer raised its projections as its pharmaceutical business recovered and its third-quarter loss narrowed.
Related stories
Italian Stocks Close Flat
Milan’s FTSE MIB closed largely unchanged at 49,942 on Tuesday as investors assessed the latest batch of third-quarter earnings. Lottomatica gained 0.9% after reporting a 5% year-o
H impact | EARNINGS | Nov 03, 2026, 05:03 PM UTC
Sacyr Reports 9-Month Net Profit of €116.3 Million
M impact | EARNINGS | Nov 03, 2026, 04:54 PM UTC
Meliá Hotels Reports Q3 EBITDA of €198.3 Million
M impact | EARNINGS | Nov 03, 2026, 04:54 PM UTC
Sacyr Reports Nine-Month Revenue of €3.78 LN
M impact | EARNINGS | Nov 03, 2026, 04:53 PM UTC
Sacyr Reports Nine-Month EBITDA of €1.11 Billion
M impact | EARNINGS | Nov 03, 2026, 04:53 PM UTC
Groupe BPCE Q3 Net Income Rises 25% to €1.4B
Groupe BPCE reported Q3-26 net banking income of €7.0B, up 9% year over year. Nine-month net income was €3.8B, up 28%.
M impact | EARNINGS | Nov 03, 2026, 04:52 PM UTC